| 名稱 | bTMB-P1 (22.91) Reference Standard |
| 型號 | CBP80001-10 |
| 報價 | ![]() |
| 特點 | bTMB-P1 (22.91) Reference Standard |
產(chǎn)品搜索
相關(guān)文章
聯(lián)系我們
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
- 詳細內(nèi)容
| CBP80001-10 | |||||||||||||||||||||||||||||||||||||||||||||||
| I. Background | |||||||||||||||||||||||||||||||||||||||||||||||
Tumor mutational burden (TMB) shows great promise as a biomarker for immuno-oncology (I-O) therapy response, but progress is hindered by the lack of a standardized TMB measurement by targeted NGS panels, and an absence of TMB reference materials.
| |||||||||||||||||||||||||||||||||||||||||||||||




